We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$459M
AUM Growth
+$339K
Cap. Flow
+$2.87M
Cap. Flow %
0.63%
Top 10 Hldgs %
26.07%
Holding
369
New
29
Increased
116
Reduced
28
Closed
14

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$5.91M
2
COP icon
ConocoPhillips
COP
+$5.85M
3
MDT icon
Medtronic
MDT
+$5.74M
4
ZBH icon
Zimmer Biomet
ZBH
+$5.73M
5
CSX icon
CSX Corp
CSX
+$5.68M

Top Sells

Rank Stock Value
1
NTAP icon
NetApp
NTAP
+$6.62M
2
JCI icon
Johnson Controls International
JCI
+$6.39M
3
GLW icon
Corning
GLW
+$6.27M
4
XOM icon
ExxonMobil
XOM
+$6.11M
5
WFC icon
Wells Fargo
WFC
+$6.07M

Sector Composition

Rank Sector Weight
1 Technology 20.86%
2 Healthcare 11.86%
3 Financials 10.89%
4 Communication Services 9.01%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
326
Viatris
VTRS
$20.5B
$1.1K ﹤0.01%
103
WBD icon
327
Warner Bros
WBD
$65.4B
$1.06K ﹤0.01%
142
ARKK icon
328
ARK Innovation ETF
ARKK
$5.84B
$835 ﹤0.01%
19
NTR icon
329
Nutrien
NTR
$31.7B
$764 ﹤0.01%
15
POST icon
330
Post Holdings
POST
$4.09B
$729 ﹤0.01%
7
BHF icon
331
Brighthouse Financial
BHF
$3.55B
$693 ﹤0.01%
16
AIG icon
332
American International
AIG
$41.8B
$668 ﹤0.01%
9
GSLC icon
333
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$642 ﹤0.01%
6
HIMS icon
334
Hims & Hers Health
HIMS
$7.13B
$633 ﹤0.01%
+31
New +$516
TSM icon
335
TSMC
TSM
$2.11T
$521 ﹤0.01%
+3
New +$455
PHO icon
336
Invesco Water Resources ETF
PHO
$2.03B
$519 ﹤0.01%
8
NUE icon
337
Nucor
NUE
$59.5B
$508 ﹤0.01%
3
GTHX
338
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$483 ﹤0.01%
212
BRBR icon
339
BellRing Brands
BRBR
$1.51B
$457 ﹤0.01%
8
FSLR icon
340
First Solar
FSLR
$25B
$451 ﹤0.01%
+2
New +$436
NIO icon
341
NIO
NIO
$12.1B
$416 ﹤0.01%
100
ATHE
342
Alterity Therapeutics
ATHE
$80.8M
$362 ﹤0.01%
200
EFA icon
343
iShares MSCI EAFE ETF
EFA
$78.4B
$313 ﹤0.01%
4
KPTI icon
344
Karyopharm Therapeutics
KPTI
$44.6M
$271 ﹤0.01%
21
NKLA
345
DELISTED
Nikola Corporation Common Stock
NKLA
$270 ﹤0.01%
33
COMP icon
346
Compass
COMP
$8.78B
$252 ﹤0.01%
70
LQDA icon
347
Liquidia Corp
LQDA
$7.46B
$228 ﹤0.01%
19
FATE icon
348
Fate Therapeutics
FATE
$291M
$200 ﹤0.01%
61
CHWY icon
349
Chewy
CHWY
$9.4B
$109 ﹤0.01%
4
AMBP.WS
350
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$89 ﹤0.01%
2,952

Similar funds

Providence Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Providence Capital Advisors held 369 positions worth $459M, up 0.07% from $458M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors's Q2 2024 filing shows 29 new, 116 increased, 28 reduced and 14 closed positions. Its largest new stake was Tyson Foods: 101,100 shares worth $5.78M. The largest sale was NetApp, an estimated $6.62M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Providence Capital Advisors's largest Q2 2024 buy was Tyson Foods: 101,100 shares worth $5.78M.
  • Providence Capital Advisors added most to Medtronic in Q2 2024, an estimated $5.74M increase.
  • Providence Capital Advisors's biggest Q2 2024 reduction was Johnson Controls International, cutting an estimated $6.39M.
  • Providence Capital Advisors fully exited NetApp in Q2 2024, selling an estimated $6.62M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $459M portfolio in Q2 2024.
  • Providence Capital Advisors opened 29 new positions and closed 14 in Q2 2024.
  • Providence Capital Advisors's portfolio value rose 0.07% quarter-over-quarter to $459M.

Based on Providence Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.